Enochian Biosciences Inc | Business Contracts

Form of Subscription Agreement (Filed With SEC on April 3, 2023)

Form of Warrant (Filed With SEC on April 3, 2023)

Amendment No.2 to Promissory Note, dated May 17, 2022 (Filed With SEC on February 27, 2023)

Security Agreement (Filed With SEC on February 23, 2023)

Amendment to Promissory Note (Filed With SEC on February 23, 2023)

Form of Amended and Restated Senior Secured Convertible Promissory Note (Filed With SEC on February 23, 2023)

Amendment to Employment Agreement between Mark Dybul, M.D. and Enochian Biosciences Inc., dated December 12, 2022 (Filed With SEC on December 16, 2022)

Employment Agreement between Enochian Biosciences, Inc. and Dr. Mark Dybul, dated August 11, 2021 (Filed With SEC on August 16, 2021)

License Agreement (Filed With SEC on April 22, 2021)

Form of Subscription Agreement (Filed With SEC on March 24, 2021)

Description of Securities (Filed With SEC on September 23, 2020)

Purchase Agreement, dated July 8, 2020, by and between the Company and Lincoln Park Capital Fund, LLC (Filed With SEC on July 14, 2020)

Registration Rights Agreement, dated July 8, 2020, by and between the Company and Lincoln Park Capital Fund, LLC (Filed With SEC on July 14, 2020)

Promissory Note (Filed With SEC on March 31, 2020)

Note Purchase Agreement (Filed With SEC on March 31, 2020)

Enochian Biosciences, Inc. 2019 Equity Incentive Plan (Filed With SEC on February 10, 2020)

License Agreement (Filed With SEC on February 3, 2020)

Offer Letter from the Company to Luisa Puche, dated December 28, 2018 (Filed With SEC on September 30, 2019)

Consulting Agreement by and between the Company and G-Tech Bio, LLC July 9, 2018 (Filed With SEC on September 30, 2019)

Amended and Restated Director Agreement by and between the Company and Mark Dybul, as amended, dated May 1, 2019 (Filed With SEC on September 30, 2019)

Lease Agreement dated June 19, 2018 (Filed With SEC on June 25, 2018)

Consulting Agreement with Carl Sandler (Filed With SEC on May 15, 2018)

Sublease Agreement (Filed With SEC on May 15, 2018)

Consulting Agreement with Weird Science (Filed With SEC on May 15, 2018)

US Subscription Agreement (Filed With SEC on February 23, 2018)

Non-US Subscription Agreement (Filed With SEC on February 23, 2018)

Form of Grant Warrant (Filed With SEC on February 9, 2018)

RS Consulting Agreement (Filed With SEC on February 9, 2018)

Amendment to CFO Service Agreement (Filed With SEC on February 9, 2018)

Form of Convertible Note Amendment (Filed With SEC on February 9, 2018)

Lease Agreement dated November 13, 2017 (Filed With SEC on November 17, 2017)

CFO Service Agreement by and between DanDrit Denmark and Mr. Robert Wolfe effective July 11, 2017 (Filed With SEC on September 29, 2017)

Promissory Note dated July 14, 2017 (Filed With SEC on July 20, 2017)

Form of Warrant (Filed With SEC on May 1, 2017)

Form of Subscription Agreement (Filed With SEC on May 1, 2017)

SECONDAMENDMENT TO ASSET PURCHASE AGREEMENT (Filed With SEC on November 10, 2016)

ASSET PURCHASE AGREEMENT (Filed With SEC on April 5, 2016)

Page 8 (Filed With SEC on March 18, 2015)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on December 31, 2014)

PLACEMENT AGENCY AGREEMENT (Filed With SEC on August 14, 2014)

PLACEMENT AGENCY AGREEMENT (Filed With SEC on July 3, 2014)

PLACEMENT AGENCY AGREEMENT (Filed With SEC on June 23, 2014)

EFS/DVS/NDA20130307CONFIDENTIAL DISCLOSURE AGREEMENT (Filed With SEC on May 16, 2014)

PLACEMENT AGENCY AGREEMENT (Filed With SEC on May 16, 2014)

Lock-Up Agreement (Filed With SEC on March 31, 2014)

Consulting Agreement (Filed With SEC on March 31, 2014)

DANDRIT BIOTECH USA, INC. 2014 EQUITY INCENTIVE PLAN (Filed With SEC on March 31, 2014)

LEASE AGREEMENT (Filed With SEC on March 31, 2014)

Law Firm P/SN. E. NielsenLawyerOur ref 284756-GGI (Filed With SEC on March 31, 2014)

LawFirmPISN.E.NielsenOurref:284756-GGI (Filed With SEC on February 14, 2014)

AGREEMENT AND PLAN OF SHARE EXCHANGE (Filed With SEC on February 14, 2014)

DANDRIT BIOTECH USA, INC. 2014 EQUITY INCENTIVE PLAN (Filed With SEC on February 14, 2014)

Consulting Agreement (Filed With SEC on February 14, 2014)

SHARE CANCELLATION AGREEMENT (Filed With SEC on February 14, 2014)

EARLY ACCESS AGREEMENT (Filed With SEC on February 14, 2014)

LOAN AGREEMENT (Filed With SEC on February 14, 2014)

On the date hereof, Ordnung ApS Danish CVR no. 3351 0950 (hereinafter referred to as Ordnung) and DanDrit Biotech A/S c/o Dina Rosenberg Danish CVR No/SE No 2602 7322 (hereinafter... (Filed With SEC on February 14, 2014)

F I X E D - T E R M L E A S E A G R E E M E N T CONCERNING B A S E M E N T R O O M Between Symbion A/S Danish (CVR) No 10 36 97 03 Fruebjergvej 3, DK-2100 Copenhagen ( hereinafter... (Filed With SEC on February 14, 2014)

1SUBJECT-MATTER (Filed With SEC on February 14, 2014)

Lett Law FirmAdvokat Sren BrinkmannJ.no. 271930-LKP (Filed With SEC on February 14, 2014)

MASTER SERVICES AGREEMENT (Filed With SEC on February 14, 2014)

Colla boration Agreement (Filed With SEC on February 14, 2014)

Alexei Kirkin Strandboulevarden 61,2nd floor to the left DK-2100Copenhagen (Filed With SEC on February 14, 2014)

Enochian Biosciences Inc (63)